Amgen Inc. buy Argus
Start price
30.12.25
/
50%
€280.15
Target price
30.12.26
€305.71
Performance (%)
19.34%
Price
12:52
€329.30
Summary
This prediction is currently active. The BUY prediction by Argus currently has a performance of 19.34%. Dividends of €5.04 are taken into consideration when calculating the performance. This prediction currently runs until 30.12.26. The prediction end date can be changed by Argus at any time. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -0.529% | -0.529% |
| iShares Core DAX® | 2,33 % | 1,01 % |
| iShares Nasdaq 100 | 1,37 % | -3,61 % |
| iShares Nikkei 225® | 2,44 % | -7,46 % |
| iShares S&P 500 | 1,26 % | 0,68 % |
Comments by Argus for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Argus from $310.00 to $360.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat